A citation-based method for searching scientific literature

Yong Chen. Biol Chem 2019
Times Cited: 6







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


How shelterin protects mammalian telomeres.
Wilhelm Palm, Titia de Lange. Annu Rev Genet 2008
50

Shelterin-Mediated Telomere Protection.
Titia de Lange. Annu Rev Genet 2018
206
33

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
Kenkichi Masutomi, Richard Possemato, Judy M Y Wong, Jennifer L Currier, Zuzana Tothova, Judith B Manola, Shridar Ganesan, Peter M Lansdorp, Kathleen Collins, William C Hahn. Proc Natl Acad Sci U S A 2005
253
33


A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
A A Chiappori, T Kolevska, D R Spigel, S Hager, M Rarick, S Gadgeel, N Blais, J Von Pawel, L Hart, M Reck,[...]. Ann Oncol 2015
85
33

Telomere diseases.
Rodrigo T Calado, Neal S Young. N Engl J Med 2009
503
33

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
201
33

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
342
33



Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
Guangtong Zhou, Xinrui Liu, Yunqian Li, Songbai Xu, Chengyuan Ma, Xinmin Wu, Ye Cheng, Zhiyun Yu, Gang Zhao, Yong Chen. Oncotarget 2016
40
33

Multiple POT1-TPP1 proteins coat and compact long telomeric single-stranded DNA.
Derek J Taylor, Elaine R Podell, Dylan J Taatjes, Thomas R Cech. J Mol Biol 2011
26
33

Inhibition of telomerase by G-quartet DNA structures.
A M Zahler, J R Williamson, T R Cech, D M Prescott. Nature 1991
869
33

Bone marrow failure and the telomeropathies.
Danielle M Townsley, Bogdan Dumitriu, Neal S Young. Blood 2014
145
33


Functional dissection of human and mouse POT1 proteins.
Wilhelm Palm, Dirk Hockemeyer, Tatsuya Kibe, Titia de Lange. Mol Cell Biol 2009
82
33

Telomeres: protecting chromosomes against genome instability.
Roderick J O'Sullivan, Jan Karlseder. Nat Rev Mol Cell Biol 2010
545
33

Telomere sequence content can be used to determine ALT activity in tumours.
Michael Lee, Erdahl T Teber, Oliver Holmes, Katia Nones, Ann-Marie Patch, Rebecca A Dagg, Loretta M S Lau, Joyce H Lee, Christine E Napier, Jonathan W Arthur,[...]. Nucleic Acids Res 2018
17
16

Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.
Yongchun Wang, Alan K Meeker, Jeanne Kowalski, Hua-Ling Tsai, Helina Somervell, Christopher Heaphy, Lauren E Sangenario, Nijaguna Prasad, William H Westra, Martha A Zeiger,[...]. Am J Pathol 2011
18
16

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
16

Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.
Greta Gandolfi, Moira Ragazzi, Dario de Biase, Michela Visani, Eleonora Zanetti, Federica Torricelli, Valentina Sancisi, Mila Gugnoni, Gloria Manzotti, Luca Braglia,[...]. Oncotarget 2017
21
16

Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy.
M Gugnoni, V Sancisi, G Gandolfi, G Manzotti, M Ragazzi, D Giordano, I Tamagnini, M Tigano, A Frasoldati, S Piana,[...]. Oncogene 2017
99
16

Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells.
Paola Caria, Rita Pillai, Tinuccia Dettori, Daniela Virginia Frau, Patrizia Zavattari, Gabriele Riva, Gabriele Romano, Fabiana Pani, Angela Bentivegna, Roberto Giovannoni,[...]. J Cancer 2017
6
16

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.
Hany I Sakr, Deborah J Chute, Christian Nasr, Charles D Sturgis. Diagn Pathol 2017
11
16

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
22
16

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Zhen Su, Jens Dannull, Benjamin K Yang, Philipp Dahm, Doris Coleman, Donna Yancey, Sylvia Sichi, Donna Niedzwiecki, David Boczkowski, Eli Gilboa,[...]. J Immunol 2005
250
16


Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells.
Alessia Ciarrocchi, Simonetta Piana, Roberto Valcavi, Giorgio Gardini, Bruno Casali. Eur J Cancer 2011
32
16

PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma.
Yu-Jen Chen, Hamish G Campbell, Anna K Wiles, Michael R Eccles, Roger R Reddel, Antony W Braithwaite, Janice A Royds. Cancer Res 2008
30
16

Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.
Xuguang Zhu, Keisuke Enomoto, Li Zhao, Yuelin J Zhu, Mark C Willingham, Paul Meltzer, Jun Qi, Sheue-Yann Cheng. Clin Cancer Res 2017
34
16

The Role of STAT3 in Thyroid Cancer.
Nadiya Sosonkina, Dmytro Starenki, Jong-In Park. Cancers (Basel) 2014
20
16

Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway.
Valentina Sancisi, Greta Gandolfi, Moira Ragazzi, Davide Nicoli, Ione Tamagnini, Simonetta Piana, Alessia Ciarrocchi. PLoS One 2013
45
16

TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Greta Gandolfi, Moira Ragazzi, Andrea Frasoldati, Simonetta Piana, Alessia Ciarrocchi, Valentina Sancisi. Eur J Endocrinol 2015
77
16

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang,[...]. Oncogene 2019
21
16

EMT in cancer.
Thomas Brabletz, Raghu Kalluri, M Angela Nieto, Robert A Weinberg. Nat Rev Cancer 2018
717
16

Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.
Semih Can Akıncılar, Ekta Khattar, Priscilla Li Shan Boon, Bilal Unal, Melissa Jane Fullwood, Vinay Tergaonkar. Cancer Discov 2016
82
16

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
623
16

Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.
Ekta Khattar, Pavanish Kumar, Chia Yi Liu, Semih Can Akıncılar, Anandhkumar Raju, Manikandan Lakshmanan, Julien Jean Pierre Maury, Yu Qiang, Shang Li, Ern Yu Tan,[...]. J Clin Invest 2016
79
16

Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer.
Silvia Cantara, Milena Pisu, Daniela Virginia Frau, Paola Caria, Tinuccia Dettori, Marco Capezzone, Serena Capuano, Roberta Vanni, Furio Pacini. J Clin Endocrinol Metab 2012
24
16


Emerging roles of telomeric chromatin alterations in cancer.
Stefano Cacchione, Annamaria Biroccio, Angela Rizzo. J Exp Clin Cancer Res 2019
16
16

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Steven I Sherman, Eric J Sherman. Lancet Oncol 2016
136
16

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
287
16

Role of telomeres and telomerase in cancer.
Jerry W Shay, Woodring E Wright. Semin Cancer Biol 2011
295
16

Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.
Uma Sinha-Datta, Izumi Horikawa, Eriko Michishita, Abhik Datta, Janitzia C Sigler-Nicot, Megan Brown, Mirdad Kazanji, J Carl Barrett, Christophe Nicot. Blood 2004
100
16

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
77
16

Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.
Peter C Hollenhorst, Mary W Ferris, Megan A Hull, Heejoon Chae, Sun Kim, Barbara J Graves. Genes Dev 2011
113
16


Predictive biomarkers for checkpoint inhibitor-based immunotherapy.
Geoffrey T Gibney, Louis M Weiner, Michael B Atkins. Lancet Oncol 2016
655
16

Novel targeted therapies and immunotherapy for advanced thyroid cancers.
George E Naoum, Michael Morkos, Brian Kim, Waleed Arafat. Mol Cancer 2018
65
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.